Sign in

or Register now

MyDiabetesCentral.com

See all of our health sites at www.HealthCentral.com
Wednesday, November, 25, 2009
  • Font size
Shedding Light on the Co-morbidities of DiabetesThe Complications of Having Rheumatoid Arthritis and Diabetes

“I probably should do that”

Dr. Bill Quick
Dr. Bill Quick
Close
Physician and Medical Director of DiabetesMonitor.com

Dr. Bill Quick and his wife Steph are the authors of one of the ...

Dr. Bill Quick

Monday, February 09, 2009
View All of Dr. Bill Quick's Posts

 

Now, back to why I chose the title for this essay ("I probably should do that"). I was at a diabetes meeting this past weekend, and was chatting with another physician-attendee about using a diabetes drug in an off-label setting. I pointed out that he might want to get the patient to sign an informed consent; his response was "I probably should do that."

 

When I was in office practice, I routinely had patients sign off on their care plans (as well as me signing off on the plans), and if a drug was to be used off-label, that was part of the care plan. So it doesn't need to be an official looking document labeled with a pretentious title like "Off-Label Use Informed Consent Plan Form." But it should be very clearly documented that the patient was aware of the off-label use, and that the patient understood the risks as well as the benefits, and agreed to the off-label use.

 

That's the ethical thing to do.

  • Font size
  • Bookmark
  • Thank you for your input
  • Save
  • RSS
  • Report Abuse

Ask a Question

Get answers from our experts and community members.

View all questions (2366) >